Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
112 Cards in this Set
- Front
- Back
|
monovalent hepatits B (HepB)
|
1 to 2 months
|
|
|
combined hepatits B (HepB)
|
6 to 18 months
|
|
|
fourth dose diphtheria, tetanus, pertussis (DTaP)
|
15 to 18 months
|
|
|
final dose diphtheria, tetanus, pertussis (DTaP)
|
4 to 6 years
|
|
|
haemophilus influenzae type b (Hib)
|
12 to 15 months
|
|
|
pneumococcal (PCV)
|
12 to 15 months
|
|
|
inactivated poliovirus (IPV)
|
6 to 18 months
|
|
|
fifth dose inactive poliovirus (IPV)
|
4 to 6 years
|
|
|
yearly influenza
|
6 months to 6 years
|
|
|
measles, mumps, rubella (MMR)
|
12 to 15 months
|
|
|
measles, mumps, and rubella vaccine (MMR)
|
4 to 6 years
|
|
|
varicella vaccine
|
12 to 15 months
|
|
|
second varicella
|
4 to 6 years
|
|
|
hepA (2 doses)
|
12 to 23 months (with 6 months apart)
|
|
|
TLR 1
|
Lipoprotiens bacteria
Staphylococcus aurus |
|
|
TLR 2
|
Lipotexhoic acid
Streptococcus pyogenes Canadida albicans |
|
|
TLR 3
|
double-stranded viral RNA
West Nile virus |
|
|
TLR 4
|
Lipopolysaccharide
Pseudomonas aeruginosa |
|
|
TLR 5
|
Flagellin
Salmonella sp. |
|
|
TLR 7
|
Single stranded viral RNA
HIV |
|
|
TLR 8
|
Single stranded viral RNA
Influenza virus |
|
|
TLR 9
|
CpG DNA
E. coli |
|
|
TLR 10
|
unknown
|
|
|
Histamine
|
Chemical Mediators with Vasoactive Effects
|
|
|
Serotonin
|
Chemical Mediators with Vasoactive Effects
|
|
|
Bradykinin
|
Chemical Mediators with Vasoactive Effects
|
|
|
Prostaglandins
|
Chemical Mediators with Vasoactive Effects
|
|
|
Compliement components
|
Mediators with Both Vasoactive and Chemotactic Effects
|
|
|
Cytokines such as interferon and interleukin
|
Mediators with Both Vasoactive and Chemotactic Effects
|
|
|
Some products of arachidonic acid metabolism
|
Mediators with Both Vasoactive and Chemotactic Effects
|
|
|
Platelet activators
|
Mediators with Both Vasoactive and Chemotactic Effects
|
|
|
Fibrin
|
Chemical Mediators with Chemotatctic Effects
|
|
|
Collagen
|
Chemical Mediators with Chemotatctic Effects
|
|
|
Mast cell chemotactic factors
|
Chemical Mediators with Chemotatctic Effects
|
|
|
Bacterial peptides, PAMPs
|
Chemical Mediators with Chemotatctic Effects
|
|
|
IgG
|
Monomer
2 Antigen Binding 80% in Serum 23 days Life Crosses Placenta Fixes Complements Phagocytes Fc Binding |
|
|
IgG
|
Long-term immunity; memory antibodies
|
|
|
IgA
|
Dimer, Monomer
4 Antigen Binding 13% in Serum 6 days Life |
|
|
IgA
|
Secretory antibody; on mucous membranes
|
|
|
IgM
|
Pentamer
10 Antigen Binding 6% in Serum 5 days Life Fixes Complement |
|
|
IgM
|
Produced at the first response to antigen; can serve as B-cell receptor
|
|
|
IgD
|
Monomer
2 Antigen Binding 1% in Serum 3 days Life |
|
|
IgD
|
Receptor on B cells
|
|
|
IgE
|
Monomer
2 Antigen Binding 0.002% in Serum 2.5 days Life Mast Cells and basophils Fc Binding |
|
|
IgE
|
Antibody of allergy; worm infections
|
|
|
Cholera
|
SQ
|
|
|
Plague
|
SQ
|
|
|
Anthrax
|
SQ
|
|
|
Meningitis (meningoccal)
|
SQ
|
|
|
Pneumococcal pneumonia
|
SQ or IM
|
|
|
Japanese encephalitis
|
SQ
|
|
|
Measles (rubeola)
|
SQ
|
|
|
Mumps (parotitis)
|
SQ
|
|
|
Rubella
|
SQ
|
|
|
Chickenpox (varicella)
|
SQ
|
|
|
Yellow fever
|
SQ
|
|
|
Meningitis (Haemophilus influenzae)
|
IM
|
|
|
Pnemococcal pneumonia
|
IM or SQ
|
|
|
Pertussis (aP)
|
IM
|
|
|
Diphtheria
|
IM
|
|
|
Tetanus
|
IM
|
|
|
Pertussis
|
IM
|
|
|
Botulism
|
IM
|
|
|
Poliomyelitis (Salk)
|
IM
|
|
|
Rabies
|
IM
|
|
|
Influenza
|
IM (or Inhaled for Live, Attenuated Viruse)
|
|
|
Hepatits A
|
IM
|
|
|
Hepatitis B
|
IM
|
|
|
Typoid
|
Oral
|
|
|
Adenovirus infection
|
Oral
|
|
|
Poliomyelitis (Sabin)
|
Oral
|
|
|
Rotavirus
|
Oral
|
|
|
Tuberculosis (BCG)
|
ID
|
|
|
Smallpox
|
MP
|
|
|
Breast Cancer
|
Trastuzumab
Herceptin |
|
|
Non Hodgkin's lymphoma
|
Retuximab
Rituxan Ibrutumomab Zevalin |
|
|
Colorectal cancer
|
Cetuxumab
Erbitux |
|
|
Acute myelogenous leukemia
|
Gemtuzumab
Mylotarg |
|
|
Asthma
|
Omalizumab
Xolair |
|
|
Organ rejection
|
Daelizumab
Zenapax |
|
|
Crohn disease
|
Infliximab
Remicade |
|
|
Respiratory syncytial virus
|
Palivizumab
Synagis |
|
|
Inhalants
|
Pollen
Dust Mold Spores Dander Animal hair Insect parts Formalin Drugs Enzymes |
|
|
Ingestants
|
Food
Food additives Drugs (asprin, penicillin) |
|
|
Injectants
|
Hymenopteran
Drugs Vaccines Serum Enzymes Hormones |
|
|
Contactants
|
Drugs
Cosmetics Heavy metals Detergents Formalin Rubber Glue Solvents Dyes |
|
|
Blood Type A
|
41, 28, 27
|
|
|
Blood Type B
|
10, 27, 20
|
|
|
Bood Type AB
|
4, 5, 7
|
|
|
Blood Type O
|
45, 40, 46
|
|
|
Systemic lupus erythematosus
|
Systemic
|
|
|
Rheumatoid anrthritis and ankylosing spondylitis
|
Systemic
|
|
|
Scleroderma
|
Systemic
|
|
|
Hashimoto's thyroditis
|
Thyroid
|
|
|
Graves disease
|
Thyroid
|
|
|
Pernicious anemia
|
Stomach lining
|
|
|
Myasthenia gravis
|
Muscle
|
|
|
Type 1 diabetes
|
Pancreas
|
|
|
Multiple Sclerosis
|
Myelin
|
|
|
Goodpasture syndrome (glomerulonephritis)
|
Kidney
|
|
|
Rheumatic fever
|
Heart
|
|
|
Direct Testing
Microscopic |
Gram stain
Acid fast stain Fluorescent Ab stain Gene probes |
|
|
Direct Testing
Macroscopic |
Direct antigen
Gene probes |
|
|
Culture/Isolation
Tests on isolates |
Biochemical
Serotyping (slide) Antimicrobic sensitivity Gene probes Phage typing Animal inoculation |
|
|
Patient
|
Immunologic and serological tests (antibody titer) on blood and other fluids
|
|
|
Patient
|
In vivo tests for reaction to microbe
|
|
|
Patient
|
Clinical signs and symptoms
|
|
|
B Cell Defects
|
Agammaglobulinemia
Hypogammaglobulinemia SIDs |
|
|
T Cell Defects
|
Thymic aplasia (DiGeorge)
Chronic mucocutaneous candidiasis |
|
|
Combinied B and T
|
SCID
X-SCIDI due to interlukin defect Wiskott-Aldrich syndrome Ataxia telangiectasia |
|
|
Phagocyte Defects
|
Chediak-Higashi syndrome
Chronic granulomatous disease Lack of surface adhesion molecules |
|
|
Complement Defects
|
Lacking one of C components
Herederitary angioedema Associated with rheumatoid disease |
